Kiora Pharmaceuticals Statistics
NASDAQ: KPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.53+0.03 (+1.20%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Kiora Pharmaceuticals by the numbers
Kiora Pharmaceuticals has a market capitalization of $11.2 million based on 4.42M shares outstanding. With trailing EPS of $-2.43, Kiora Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.6% below its 50-day average and 5.8% above its 200-day average.
Average daily trading volume is 17.06K shares, or about $43,169 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KPRX valuation vs. peer median
| Metric | KPRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $11.19M | $10.97M | +2% |
| Avg. volume | 17.06K | 567.08K | -97% |
Peer median across 8 companies: BLRX, VTGN, GTBP, TOVX, APUS, MDCX, PHIO, ADIL.
Valuation
- Market cap
- $11.19M
- EPS (TTM)
- $-2.43
- Shares outstanding
- 4.42M
Price and trading
- Previous close
- 2.50
- Open
- 2.51
- Day range
- 2.49 – 2.54
- 52-week range
- 1.77 – 2.91
- 52-week change
- -7.33%
- Beta
- —
- Volume
- 21.01K
- Average volume
- 17.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 11.19M
- Forward Pe
- -1.13
- Eps
- -2.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.91
- Week52 Low
- 1.77
- Avg Volume
- 17,063.00
- Shares Outstanding
- 4.42M
- Ma50
- 2.60
- Ma200
- 2.39
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -13.06%
- Pct From52w Low
- 43.34%